Taysha Gene Therapies, Inc. (TSHA)
5.21
-0.29
(-5.27%)
USD |
NASDAQ |
Jan 02, 12:07
Taysha Gene Therapies Market Cap: 1.427B for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AngioDynamics, Inc. | 521.18M |
| Anavex Life Sciences Corp. | 319.42M |
| Bolt Biotherapeutics, Inc. | 10.74M |
| Neurogene, Inc. | 319.09M |
| Aspire Biopharma Holdings, Inc. | 15.28M |
Market Cap Related Metrics
| PS Ratio | 232.33 |
| PEG Ratio | -0.0155 |
| Price to Book Value | 6.517 |
| Price | 5.21 |
| Earnings Yield | -6.80% |
| PEGY Ratio | -0.0155 |